Summary: This video explores several approaches to direct-to-patient clinical supply that are in use today and how they can be used to flexibly support today’s decentralized clinical trials.

As the number of global scale clinical trials continues to grow, sponsors will need to implement methods to ensure their protocols are executed properly.

Clinical supply packaging strategies can greatly impact the ability to properly execute study protocols.

Summary: In 2018, over 40% of new clinical studies had sites in the APAC region this trend is expected to continue to grow in the coming years.

Summary: Catalent and Fierce Pharma surveyed 234 individuals involved in clinical supply and clinical operations to better understand the industry perception around importance of having a direct-to-patient option...

Summary: Overcoming complex blinding and masking challenges in clinical trials requires a balance of strategy and adaptability. When conducting clinical trials...

Summary: With the growth in semi and fully remote clinical studies, the ability to offer direct-to-patient distribution of clinical supplies is becoming increasingly important for clinical...

Summary: With an increasing number of clinical studies being conducted in the Asia-Pacific (APAC) region, there is a growing need for streamlining import and export strategies...

Summary: Direct-to-patient (DTP) distribution of clinical supplies provides trial sponsors with the opportunity to support improved recruitment and retention rates for their studies by removing or reducing the travel...

Summary: Most commercial contract drug packagers do not provide consistent scheduling for low-volume drugs, which creates supply challenges. In fact, a drug packaging delay can create a market shortage that triggers...